Chrystyna Bedrij Stecyk - May 11, 2023 Form 4 Insider Report for VACCINEX, INC. (VCNX)

Role
Director
Signature
/s/ Scott E. Royer, Attorney-in-Fact for Chrystyna Bedrij Stecyk
Stock symbol
VCNX
Transactions as of
May 11, 2023
Transactions value $
$0
Form type
4
Date filed
5/15/2023, 04:33 PM
Previous filing
May 13, 2022
Next filing
May 14, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCNX Stock Option (Right to Buy) Award $0 +144K $0.00 144K May 11, 2023 Common Stock 144K $0.41 Direct F4
holding VCNX Stock Option (Right to Buy) 25.1K May 11, 2023 Common Stock 25.1K $3.95 Direct F1
holding VCNX Stock Option (Right to Buy) 28.6K May 11, 2023 Common Stock 28.6K $2.15 Direct F2
holding VCNX Stock Option (Right to Buy) 53.3K May 11, 2023 Common Stock 53.3K $1.12 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first.
F2 This option expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first.
F3 This option expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first.
F4 This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 8, 2033 or five years following retirement or cessation of services, whichever occurs first.